1574 related articles for article (PubMed ID: 27410431)
1. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
Löwe LC; Gaser C; Franke K;
PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
[TBL] [Abstract][Full Text] [Related]
2. The effect of ApoE ε4 on longitudinal brain region-specific glucose metabolism in patients with mild cognitive impairment: a FDG-PET study.
Paranjpe MD; Chen X; Liu M; Paranjpe I; Leal JP; Wang R; Pomper MG; Wong DF; Benzinger TLS; Zhou Y;
Neuroimage Clin; 2019; 22():101795. PubMed ID: 30991617
[TBL] [Abstract][Full Text] [Related]
3. Searching for Primary Predictors of Conversion from Mild Cognitive Impairment to Alzheimer's Disease: A Multivariate Follow-Up Study.
López ME; Turrero A; Cuesta P; López-Sanz D; Bruña R; Marcos A; Gil P; Yus M; Barabash A; Cabranes JA; Maestú F; Fernández A
J Alzheimers Dis; 2016 Mar; 52(1):133-43. PubMed ID: 27060953
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
5. Integration and relative value of biomarkers for prediction of MCI to AD progression: spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers.
Da X; Toledo JB; Zee J; Wolk DA; Xie SX; Ou Y; Shacklett A; Parmpi P; Shaw L; Trojanowski JQ; Davatzikos C;
Neuroimage Clin; 2014; 4():164-73. PubMed ID: 24371799
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in the association of APOE ε4 genotype with longitudinal hippocampal atrophy in cognitively normal older people.
Shen S; Zhou W; Chen X; Zhang J;
Eur J Neurol; 2019 Nov; 26(11):1362-1369. PubMed ID: 31102429
[TBL] [Abstract][Full Text] [Related]
7. Independent and Interactive Influences of the APOE Genotype and Beta-Amyloid Burden on Cognitive Function in Mild Cognitive Impairment.
Seo EH; Kim SH; Park SH; Kang SH; Choo IH;
J Korean Med Sci; 2016 Feb; 31(2):286-95. PubMed ID: 26839485
[TBL] [Abstract][Full Text] [Related]
8. Apolipoprotein E genotypes and plasma levels in mild cognitive impairment conversion to Alzheimer's disease: A follow-up study.
Scarabino D; Broggio E; Gambina G; Maida C; Gaudio MR; Corbo RM
Am J Med Genet B Neuropsychiatr Genet; 2016 Dec; 171(8):1131-1138. PubMed ID: 27604972
[TBL] [Abstract][Full Text] [Related]
9. BrainAGE in Mild Cognitive Impaired Patients: Predicting the Conversion to Alzheimer's Disease.
Gaser C; Franke K; Klöppel S; Koutsouleris N; Sauer H;
PLoS One; 2013; 8(6):e67346. PubMed ID: 23826273
[TBL] [Abstract][Full Text] [Related]
10. Predictability of polygenic risk score for progression to dementia and its interaction with APOE ε4 in mild cognitive impairment.
Pyun JM; Park YH; Lee KJ; Kim S; Saykin AJ; Nho K;
Transl Neurodegener; 2021 Aug; 10(1):32. PubMed ID: 34465370
[TBL] [Abstract][Full Text] [Related]
11. APOE Genotypes and Brain Imaging Classes in Normal Cognition, Mild Cognitive Impairment, and Alzheimer's Disease: A Longitudinal Study.
Camarda C; Torelli P; Pipia C; Sottile G; Cilluffo G; Camarda R
Curr Alzheimer Res; 2020; 17(8):766-780. PubMed ID: 33167837
[TBL] [Abstract][Full Text] [Related]
12. APOE-dependent phenotypes in subjects with mild cognitive impairment converting to Alzheimer's disease.
Morgen K; Frölich L; Tost H; Plichta MM; Kölsch H; Rakebrandt F; Rienhoff O; Jessen F; Peters O; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Hampel H; Teipel SJ; Pantel J; Heuser I; Wiltfang J; Rüther E; Kornhuber J; Maier W; Meyer-Lindenberg A
J Alzheimers Dis; 2013; 37(2):389-401. PubMed ID: 23948881
[TBL] [Abstract][Full Text] [Related]
13. Apolipoprotein E genotype is not associated with cognitive impairment in older adults with bipolar disorder.
Kerr DS; Stella F; Radanovic M; Aprahamian I; Bertollucci PH; Forlenza OV
Bipolar Disord; 2016 Feb; 18(1):71-7. PubMed ID: 26877211
[TBL] [Abstract][Full Text] [Related]
14. Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease.
Zhang H; Therriault J; Kang MS; Ng KP; Pascoal TA; Rosa-Neto P; Gauthier S;
Alzheimers Res Ther; 2018 Aug; 10(1):80. PubMed ID: 30115118
[TBL] [Abstract][Full Text] [Related]
15. Apolipoprotein E genotype and cerebrovascular alterations can influence conversion to dementia in patients with mild cognitive impairment.
Viticchi G; Falsetti L; Vernieri F; Altamura C; Altavilla R; Luzzi S; Bartolini M; Provinciali L; Silvestrini M
J Alzheimers Dis; 2014; 41(2):401-10. PubMed ID: 24625799
[TBL] [Abstract][Full Text] [Related]
16. Interaction between Apolipoprotein E and Butyrylcholinesterase Genes on Risk of Alzheimer's Disease in a Prospective Cohort Study.
Chuang YF; Varma V; An Y; Tanaka T; Davatzikos C; Resnick SM; Thambisetty M
J Alzheimers Dis; 2020; 75(2):417-427. PubMed ID: 32250307
[TBL] [Abstract][Full Text] [Related]
17. Association between white matter hyperintensity severity and cognitive impairment according to the presence of the apolipoprotein E (APOE) ε4 allele in the elderly: retrospective analysis of data from the CREDOS study.
Son SJ; Lee KS; Lee Y; Baek JH; Choi SH; Na DL; Seo SW; Oh BH; Hong CH
J Clin Psychiatry; 2012 Dec; 73(12):1555-62. PubMed ID: 23146133
[TBL] [Abstract][Full Text] [Related]
18. The apolipoprotein E gene affects the three-year trajectories of compensatory neural processes in the left-lateralized hippocampal network.
Ye Q; Su F; Shu H; Gong L; Xie C; Zhang Z; Bai F
Brain Imaging Behav; 2017 Oct; 11(5):1446-1458. PubMed ID: 27734307
[TBL] [Abstract][Full Text] [Related]
19. The interaction of APOE genotype by age in amnestic mild cognitive impairment: a voxel-based morphometric study.
Chen J; Shu H; Wang Z; Liu D; Shi Y; Zhang X; Zhang Z
J Alzheimers Dis; 2015; 43(2):657-68. PubMed ID: 25114090
[TBL] [Abstract][Full Text] [Related]
20. The effect of Alzheimer's disease risk factors on brain aging in normal Chineses: Cognitive aging and cognitive reserve.
Wang M; Ren Q; Shi Y; Shu H; Liu D; Gu L; Xie C; Zhang Z; Wu T; Wang Z;
Neurosci Lett; 2022 Feb; 771():136398. PubMed ID: 34923042
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
